How brain immune cells and amyloid contribute to delirium in dementia

Microglia-Amyloid interactions in delirium superimposed on dementia

NIH-funded research Duke University · NIH-11239019

This project uses a gentle, noninvasive vagus nerve stimulation to try to reduce brain inflammation and amyloid buildup after surgery in people with Alzheimer’s-type dementia.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionDuke University NIH-funded
Lab location1 site (Durham, United States)
Project IDNIH-11239019 on NIH RePORTER

What this research studies

Researchers use an Alzheimer-like mouse model that receives a common orthopedic surgery to mimic postoperative delirium on top of dementia and study what happens at the blood-brain barrier and in microglia (brain immune cells). They map immune-cell changes and amyloid-β deposits after surgery to define the immune patterns linked to delirium superimposed on dementia. The team tests brief percutaneous vagus nerve stimulation (pVNS) to see if it can normalize microglial activity and lower amyloid levels after surgery, with the goal of identifying pathways that could be targeted to prevent or lessen postoperative cognitive decline.

Who could benefit from this research

Good fit: The most relevant patients would be older adults with Alzheimer’s-type dementia or other dementias who need surgery, especially orthopedic procedures like hip or tibial fracture repair.

Not a fit: People without dementia or those whose delirium stems from non-surgical causes are less likely to benefit directly from this line of research.

Why it matters

Potential benefit: If successful, this work could point to a non-drug way to reduce post-surgical delirium and limit worsening of Alzheimer’s symptoms after surgery.

How similar studies have performed: Prior animal work showed surgery can trigger acute amyloid deposition in Alzheimer-model mice and vagus nerve stimulation has reduced inflammation in other settings, but applying pVNS to prevent postoperative delirium in dementia models is a relatively new approach.

Where this research is happening

Durham, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.